Testing a new medication to reduce mucus and inflammation in severe asthma

This is a small pilot study testing whether Dupilumab, an injectable medication, can help people with severe asthma by reducing mucus plugs in the lungs and lowering inflammation. The medication works by targeting Type 2 asthma, a specific type of asthma driven by certain immune responses. Researchers want to understand how this treatment affects your lungs and how you feel.

Severe asthma can be hard to control even with strong medications, and mucus buildup in the airways makes breathing harder. This trial is exploring whether this medication can tackle both the mucus and the underlying inflammation that makes severe asthma so difficult to manage.